2023年,印度的医药和抗生素出口占美国进口的13.1%,成为第三大进口国。 2023 sees a 13.1% share of India's medicine and antibiotic exports in US imports, making it the third-largest importer.
印度的医药和抗生素出口在2023年大幅增长,占美国进口的13.1%,成为第三大进口国。 India's medicine and antibiotic exports have increased significantly in 2023, with a 13.1% share in US imports, making it the third-largest importer. 对意大利的抗生素出口上升到2.12%,印度的竞争力在德国的磁共振仪器市场上正在增长。 Antibiotic exports to Italy rose to 2.12%, and India's competitiveness is growing in Germany's MRI apparatus market. 这些增长归因于政府对国内药品生产和PLI计划的关注。 The increases are attributed to government focus on domestic pharmaceutical production and the PLI scheme.